Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma (Q57205836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

main subject

hepatocellular carcinoma

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

T T Wu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

H C Hsu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

D S Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

I J Su

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

S L Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

S M Chuang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 February 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

45-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B Antigen and Antibody in Blood Donors: An Epidemiologic Study

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Delayed HBsAg clearance in chronic hepatitis B viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

2. Inhibition of hepatitis B viral replication by lymphoblastoid interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980008-9

7 January 2021

10.1016/S0168-8278(87)80008-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3033059%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference